Esther Schoutrop

Mesothelin-Specific CAR T Cells Target Ovarian Cancer

K. Lehti, J. Carlson, Moustapha Hassan, 2021, Cancer Research.

Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality

R. Kiessling, I. Magalhaes, T. Poiret, 2022, Oncoimmunology.

Profound Functional Suppression of Tumor-Infiltrating T-Cells in Ovarian Cancer Patients Can Be Reversed Using PD-1-Blocking Antibodies or DARPin® Proteins

U. Fiedler, Jennifer Krieg, D. Snell, 2020, Journal of immunology research.

Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis

J. Bartek, M. Maeurer, D. Valentini, 2017, EBioMedicine.

Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models

J. Henriksson, Moustapha Hassan, I. Magalhaes, 2023, Journal for ImmunoTherapy of Cancer.

Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer

M. Maeurer, D. Valentini, Martin Rao, 2018, Journal of Translational Medicine.

Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment.

S. Lheureux, K. Lehti, I. Magalhaes, 2022, Seminars in cancer biology.

Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer

M. Maeurer, D. Valentini, Martin Rao, 2018, Journal of Translational Medicine.